Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • US Politics
    US Politics
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

Article Tools/Herramientas de artículos

+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña




Globe NewsWire News Distribution Service


NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against CorMedix Inc. (“CorMedix” or the “Company”) (NASDAQ: CRMD) on behalf of CorMedix stockholders. Our investigation concerns whether CorMedix has violated the federal securities laws and/or engaged in other unlawful business…


Posted: 2025-03-28 01:00:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related Bing News Search Results

Press Release: CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the Firm - Newscast

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Tue, 08 Apr 2025 00:30:00 GMT The preliminary financial information presented in this press release is based on CorMedix’s current expectations and may be adjusted as a result of, among other things, the completion of the ...

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Tue, 25 Mar 2025 04:30:00 GMT Joe Todisco, CorMedix CEO, commented ... Non-GAAP Financial MeasuresThis release includes certain non-GAAP financial measures, including EBITDA and adjusted EBITDA, which are intended as ...

INVESTOR ALERT: Investigation Of Cormedix Inc. (CRMD) Announced By Holzer & Holzer, LLC

Mon, 24 Mar 2025 22:15:00 GMT During the Company's earnings call held the same day, Cormedix noted that“we do expect to begin to see some net price erosion beginning in the second quarter of 2025.” Following this news ...



Blow Us A Whistle




Related Product Search/Búsqueda de productos relacionados